Diabetes and weight loss drug Wegovy could also cut cardiovascular risk - CBS News

The maker of diabetes and weight loss medication Wegovy said a trial found that the drug can also cut the risk of cardiovascular disease by 20%.

Wegovy, Mounjaro and the future of weight loss drugs

MEDIA COVERAGE: Obesity Medication Proves Effective in Treating

THE SKINNY SHOT: Weight loss drug in high demand in Austin

Weight loss drug Wegovy cut risk of serious heart problems by 20

Wegovy cuts risk of serious heart problems by 20%, study finds

Celine Gounder, MD, ScM, FIDSA on LinkedIn: The next wave of GLP-1

Why Is It So Difficult For Patients To Get Wegovy?

Diabetes and weight loss drug Wegovy could also cut cardiovascular

Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20

Wegovy weight-loss drug appears to reduce heart attack, stroke risk

Obesity drug Wegovy cut risk of serious heart problems by 20

Drugs like Ozempic and Wegovy help with weight loss but price can

Weight-loss drugs: Why employers are reluctant to cover them

Wegovy weight-loss drug reduces serious heart problems by 20

Understanding Bariatric Surgery